SARAF

SARAF is an endoplasmic reticulum (and plasma membrane) single-pass membrane protein that functions as a negative regulator of store-operated calcium entry (SOCE), preventing Ca2+ overfilling of intracellular stores by associating with STIM1 to drive slow Ca2+-dependent inactivation (SCDI) of the CRAC channel (PMID:22464749). SARAF acts through a dual mechanism: after ER Ca2+ depletion it facilitates a conformational change in STIM1 that relieves the constraint imposed by the STIM1 inactivation domain (aa 475-483), promoting initial STIM1 activation and Orai1 coupling, and after cytosolic Ca2+ rises it cooperates with the STIM1 inactivation/CTID region (aa 448-530) to enforce SCDI (PMID:34705029, PMID:23816623). This interaction is temporally choreographed — store depletion transiently dissociates SARAF from STIM1 and shifts it onto the Orai1 C-terminus before re-association — and is gated by the cytosolic Ca2+ sensor EFHB and by STIM1 Y316 phosphorylation (PMID:27068144, PMID:30481768, PMID:30975919). Its luminal domain adopts a novel 10-stranded β-sandwich fold that forms a reversible domain-swapped dimer essential for proper SOCE inactivation (PMID:31082439). SARAF additionally restrains STIM1-independent Ca2+ entry through direct plasma membrane interactions with the Orai1 subunits of ARC channels and with TRPC1 (but not TRPC6) (PMID:26817842, PMID:27506849). SARAF protein stability is set by ALG-2, which binds its cytosolic domain and shields PPXY motifs from NEDD4-family E3 ligase-mediated ubiquitination (PMID:32878247). Physiologically, SARAF tunes Ca2+ signaling in acinar cells (where its loss worsens acute pancreatitis), T lymphocytes, platelets, endothelial cells, and cardiomyocytes, where it links sarcoplasmic reticulum Ca2+ homeostasis to mTORC1-driven protein synthesis and hypertrophic growth (PMID:31493399, PMID:34705029, PMID:38062782, PMID:33748129, PMID:32173353).

1. 2012 High

   Established SARAF as the molecular component responsible for limiting SOCE, answering how cells prevent Ca2+ overfilling of stores via STIM1.

   Evidence Heterologous expression, RNAi, mutagenesis, electrophysiology, Co-IP and Ca2+ imaging defining SARAF-STIM1-mediated SCDI

   PMID:22464749

   Open questions at the time

   • Did not define the STIM1 region mediating SARAF access
   • Structural basis of SARAF function unresolved
   • Did not address non-STIM1 channel targets
2. 2013 High

   Mapped the STIM1 C-terminal inhibitory domain (CTID, aa 448-530) that gates SARAF access to the SOAR region, explaining how STIM1 itself controls when SARAF can act.

   Evidence Homology modeling, deletion mutagenesis, Co-IP, electrophysiology and Ca2+ imaging

   PMID:23816623

   Open questions at the time

   • Atomic structure of the STIM1-SARAF interface not solved
   • Did not establish the temporal order of SARAF engagement
3. 2016 Medium

   Showed SARAF interactions are temporally dynamic and extend beyond STIM1 to Orai1, ARC channels, and TRPC1, revealing STIM1-independent regulatory roles at the plasma membrane.

   Evidence Reciprocal Co-IP with Orai1 deletion mutants and blocking peptides, subcellular fractionation, RNAi, and Ca2+ imaging across multiple cell lines

   PMID:26817842 PMID:27068144 PMID:27414851 PMID:27506849

   Open questions at the time

   • Binding interfaces on Orai1, ARC channels, and TRPC1 not mapped at residue level
   • STIM1-dependence of PM trafficking based on a single localization experiment
   • Whether these interactions are direct vs. complex-mediated unresolved
4. 2018 Medium

   Identified EFHB as a cytosolic Ca2+ sensor required for the STIM1-SARAF dynamic interaction, providing an upstream Ca2+-dependent switch controlling SARAF dissociation.

   Evidence Co-IP, RNAi silencing, overexpression, Ca2+ imaging and NFAT translocation assays

   PMID:30481768

   Open questions at the time

   • Whether EFHB binds SARAF directly is unknown
   • Structural/mechanistic basis of EFHB-driven dissociation unresolved
5. 2019 High

   Determined the SARAF luminal domain structure as a domain-swapped β-sandwich dimer and showed dimerization is functionally essential, linking molecular architecture to SOCE control.

   Evidence X-ray crystallography, in-cell FRET, and structure-guided domain-swap mutant with functional SOCE assays

   PMID:31082439

   Open questions at the time

   • Structure of the full-length protein or STIM1 complex not solved
   • How luminal dimerization is transmitted to cytosolic regulatory output unknown
6. 2019 High

   Connected SARAF function to physiological Ca2+ signaling in vivo, showing it protects acinar cells from Ca2+ overload and that its loss exacerbates acute pancreatitis.

   Evidence CRISPR knock-in, knockout and overexpression mice, FRET, Co-IP, Ca2+ imaging, and in vivo pancreatitis models

   PMID:31493399

   Open questions at the time

   • Mechanism distinguishing stable vs. transient STIM1-SARAF binding across stimulus intensity not fully resolved
   • Degradation pathway during pancreatitis not molecularly defined here
7. 2019 Medium

   Showed STIM1 Y316 phosphorylation modulates SARAF engagement, adding a post-translational layer to SCDI control.

   Evidence Y316F mutagenesis, Co-IP, SARAF knockdown rescue, ICRAC electrophysiology and colocalization across three cell lines

   PMID:30975919

   Open questions at the time

   • Kinase responsible for Y316 phosphorylation not identified
   • Whether phosphorylation directly alters the SARAF interface unknown
8. 2020 Medium

   Defined how SARAF abundance is controlled, showing ALG-2 binds its cytosolic domain to block NEDD4-family ubiquitination of PPXY motifs and stabilize the protein.

   Evidence In vitro pulldown, GFP pulldown, Co-IP, mutagenesis, half-life and ubiquitination assays in HEK293 cells

   PMID:32878247

   Open questions at the time

   • Specific NEDD4-family ligase(s) acting in vivo not pinned down
   • Physiological triggers that shift the ALG-2/ubiquitination balance unclear
9. 2020 Medium

   Linked SARAF-controlled SR Ca2+ homeostasis to mTORC1 activation and cardiomyocyte hypertrophic growth, extending SARAF function to downstream growth signaling.

   Evidence Knockout and cardiomyocyte-specific overexpression mice, rapamycin treatment, protein synthesis assays, echocardiography and Ca2+ measurements

   PMID:32173353

   Open questions at the time

   • Molecular link between Ca2+ signaling and mTORC1 not defined
   • Single lab; tissue-specificity of the growth axis not broadly tested
10. 2021 High

    Resolved the dual mechanistic role of SARAF in CRAC channel function — both promoting initial STIM1 activation and enforcing later SCDI via the STIM1 inactivation domain — and showed it is required for TCR-evoked transcription.

    Evidence SARAF loss-of-function, STIM1 ID mutagenesis, FRET, CRAC electrophysiology, confocal imaging and T-cell gene expression assays

    PMID:34705029

    Open questions at the time

    • Conformational details of the STIM1 change SARAF induces not structurally resolved
    • How the same protein switches between activating and inactivating roles mechanistically unresolved
11. 2021 Medium

    Extended SARAF-Orai1 function to endothelial biology, implicating it in VEGF-driven Ca2+ signaling and angiogenic behavior.

    Evidence siRNA knockdown, proximity ligation assay, immunostaining, Ca2+ imaging, and tube formation/proliferation/migration assays in HUVECs

    PMID:33748129

    Open questions at the time

    • Whether the SARAF-Orai1 PLA signal reflects direct binding unresolved
    • Downstream angiogenic signaling pathway not mapped
12. 2023 Medium

    Demonstrated that altered SARAF abundance reshapes Ca2+ signaling in disease-relevant contexts — impairing platelet aggregation when overexpressed and restraining tumor cell aggressiveness via its cytoplasmic region.

    Evidence Co-IP, ubiquitination assays, and overexpression in megakaryocyte lines for platelets; C-terminal SARAF overexpression with in vitro/in vivo assays in triple-negative breast cancer

    PMID:36982380 PMID:38062782

    Open questions at the time

    • Causal contribution of SARAF dysregulation to disease versus correlation not fully established
    • Cytoplasmic fragment mechanism of SOCE suppression not defined at residue level

• How SARAF physically toggles between promoting STIM1 activation and enforcing channel inactivation, and the atomic structure of the SARAF-STIM1-Orai1 complex, remain unresolved.
• No structure of the cytosolic domain or its STIM1 contacts
• Mechanism coupling luminal dimerization to cytosolic regulatory output unknown
• Determinants of the dual activating/inactivating switch unresolved